Proactive Investors - Run By Investors For Investors

Collagen Solutions 'well on track' with plans for CE Mark and first surgery by March

Jamal Rushdy, chief executive of Collagen Solutions PLC (LON:COS), discusses with Proactive London's Andrew Scott the group's trading update for the six months to September 2018.

Revenue and other income are forecast to be £2.10mln for the six months to September 30, some 13% higher than the £1.86mln it achieved for the same period last year.

Collagen signed nine new customer deals in the first half, cpmpared to eight in the same period last year, while the average expected value of those deals also increased.

 
Meet Faron Pharmaceuticals Ltd, Belvoir Lettings, Silence Therapeutics PLC, ANGLE PLC and ReNeuron Group PLC at our event, London , 23 May 2019. Register here »
View full COS profile View Profile

Collagen Solutions PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use